Maternal Respiratory Syncytial Virus (RSV) Vaccination: Current Status and Comparison to Monoclonal Antibodies (mAbs) for RSV Prevention in Infants and Children

Spremljeno u:
Bibliografski detalji
Izdano u:Journal of Mother and Child vol. 29, no. 1 (2025), p. 93-101
Glavni autor: Ahila, Ali
Daljnji autori: Laiba, Shamim, Ibrahim, Ahmed, Humayun Muhammad Abdullah, Khan, Muhammad Hamza, Anum, Akbar, Jindal Sanmit, Shahzaib, Ahmed, Shrestha Jamuna, Nveed, Muhammad Abdullah
Izdano:
De Gruyter Brill Sp. z o.o., Paradigm Publishing Services
Teme:
Online pristup:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

MARC

LEADER 00000nab a2200000uu 4500
001 3240142491
003 UK-CbPIL
022 |a 2719-6488 
022 |a 2719-535X 
022 |a 1428-345X 
022 |a 2354-0060 
024 7 |a 10.34763/jmotherandchild.20252901.d-25-00012  |2 doi 
035 |a 3240142491 
045 2 |b d20250101  |b d20251231 
100 1 |a Ahila, Ali  |u Department of Internal Medicine, Dow Medical College , Karachi , Pakistan 
245 1 |a Maternal Respiratory Syncytial Virus (RSV) Vaccination: Current Status and Comparison to Monoclonal Antibodies (mAbs) for RSV Prevention in Infants and Children 
260 |b De Gruyter Brill Sp. z o.o., Paradigm Publishing Services  |c 2025 
513 |a Journal Article 
520 3 |a Respiratory Syncytial Virus (RSV) causes over 50,000 hospitalizations annually among children under five years of age, leading to long-term consequences, such as asthma. Monoclonal antibodies (mAb) have been recommended for prevention, but their limitations have prompted the search for alternative preventive measures. The recent Food and Drug Administration (FDA) approval of a maternal RSV vaccine with 80% efficacy in protecting infants up to 90 days post-birth marks a significant advancement. Our narrative review investigates the differences in RSV immunization in pregnant mothers versus infants and children, with the goal of identifying factors that influence parental decisions. This study provides insights for optimising preventive strategies, and the results highlight the importance of maternal vaccination in combating RSV in children. 
653 |a Clinical trials 
653 |a Infections 
653 |a Monoclonal antibodies 
653 |a Glycoproteins 
653 |a Vaccines 
653 |a Fatalities 
653 |a Respiratory syncytial virus 
653 |a Lung diseases 
653 |a Age 
653 |a Health care 
653 |a Hospitalization 
653 |a Medical research 
653 |a Proteins 
700 1 |a Laiba, Shamim  |u Department of Internal Medicine, Sindh Medical College , Karachi , Pakistan 
700 1 |a Ibrahim, Ahmed  |u Department of Internal Medicine , Faculty of Medicine, Alexandria University , Alexandria , Egypt 
700 1 |a Humayun Muhammad Abdullah  |u Department of Pediatrics, Shalamar Institute of Health Sciences , Lahore , Pakistan 
700 1 |a Khan, Muhammad Hamza  |u Department of Internal Medicine, Karachi Medical and Dental College , Karachi , Pakistan 
700 1 |a Anum, Akbar  |u Department of Pediatrics , University of Nebraska Medical Center , Omaha , Nebraska , USA 
700 1 |a Jindal Sanmit  |u Department of Department of Population Health and Leadership , University of New Haven , Connecticut , USA 
700 1 |a Shahzaib, Ahmed  |u Department of Internal Medicine, Fatima Memorial Hospital College of Medicine and Dentistry , Lahore , Pakistan 
700 1 |a Shrestha Jamuna  |u Department of Pediatrics, Manipal College of Medical Sciences , Pokhara , Nepal 
700 1 |a Nveed, Muhammad Abdullah  |u Department of Internal Medicine, Dow Medical College , Karachi , Pakistan 
773 0 |t Journal of Mother and Child  |g vol. 29, no. 1 (2025), p. 93-101 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3240142491/abstract/embedded/75I98GEZK8WCJMPQ?source=fedsrch 
856 4 0 |3 Full Text + Graphics  |u https://www.proquest.com/docview/3240142491/fulltextwithgraphics/embedded/75I98GEZK8WCJMPQ?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3240142491/fulltextPDF/embedded/75I98GEZK8WCJMPQ?source=fedsrch